[
    [
        {
            "time": "",
            "original_text": "复星系大举减持石大胜华，北京哲厚3.3亿元接手逾8%股份",
            "features": {
                "keywords": [
                    "复星系",
                    "减持",
                    "石大胜华",
                    "北京哲厚",
                    "3.3亿元",
                    "8%股份"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "化工"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "复星系大举减持石大胜华，北京哲厚3.3亿元接手逾8%股份",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "港股异动︱子公司四价流感疫苗获临床试验批准 复星医药(02196)现涨4.17%",
            "features": {
                "keywords": [
                    "港股异动",
                    "子公司",
                    "四价流感疫苗",
                    "临床试验批准",
                    "复星医药",
                    "涨4.17%"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "港股异动︱子公司四价流感疫苗获临床试验批准 复星医药(02196)现涨4.17%",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        }
    ]
]